Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07227922
PHASE1

Clofutriben Pharmacokinetics in Patients With Impaired Renal Function

Sponsor: Sparrow Pharmaceuticals

View on ClinicalTrials.gov

Summary

This is a Phase 1, single-center, open-label, single-dose trial. Sixteen participants are planned: 8 participants with moderate renal impairment and 8 matched control participants with normal renal function.

Key Details

Gender

All

Age Range

18 Years - 83 Years

Study Type

INTERVENTIONAL

Enrollment

16

Start Date

2025-11-30

Completion Date

2026-07-01

Last Updated

2025-12-23

Healthy Volunteers

Yes

Interventions

DRUG

12mg clofutriben

Each participant will receive a single oral dose of clofutriben

Locations (1)

Orlando Clinical Research Center

Orlando, Florida, United States